Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BDH IndustriesBOM:524828 +0.46%78 Gross Margin % is 26.43% as of Mar. 2026, which is 25% below its 10-year median of 35.10. GuruFocus rates BOM:524828 with a GF Score™ of 78/100 and a GF Value™ of ₹391.10 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 942 Drug Manufacturers companies, BDH Industries ranks worse than 83.86% on this metric.
BDH Industries Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.2%.
The historical rank and industry rank for BDH Industries's Gross Margin % or its related term are showing as below:
BOM:524828'
s Gross Margin % Range Over the Past 10 Years
Min: 25.82 Med: 35.1 Max: 40.03
Current: 27.14
During the past 13 years, the highestGross Margin % of BDH Industries was 40.03%. The lowest was 25.82%. And the median was 35.10%.
BOM:524828's Gross Margin % is ranked worse than 83.86% of 942
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BOM:524828: 27.14
BDH Industries had a gross margin of 26.43% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for BDH Industries was -2.20% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
BDH Industries had a gross margin of 26.43% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
BDH Industries Gross Margin % Related Terms
BDH Industries Gross Margin % Historical Data
* Premium members only.
The historical data trend for BDH Industries's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BDH Industries Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Gross Margin % distribution charts can be found below:
* The bar in red indicates where BDH Industries's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
BDH Industries (BOM:524828) has a Gross Margin % of 26.43% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on BDH Industries and its competitors. This is 25% below median its historical median of 35.10. Over the past decade, BDH Industries' Gross Margin % has ranged from 25.82 to 40.03. According to the industry distribution chart, BDH Industries ranks #790 out of 942 companies in the Drug Manufacturers industry, placing it in the top 83.9%.
Is BDH Industries' Gross Margin % too high?
BDH Industries' current Gross Margin % of 26.43% is 25% below median its 10-year median of 35.10. Over the past 10 years, this metric has ranged from a low of 25.82 to a high of 40.03. The Drug Manufacturers industry median Gross Margin % is 48.54. BDH Industries' value of 26.43% is 45.6% below this industry median. Based on the distribution chart, BDH Industries ranks #790 out of 942 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, BDH Industries has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BDH Industries' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BDH Industries ranks #790 out of 942 companies for Gross Margin %. This places BDH Industries in the lower half of its industry. The industry median Gross Margin % is 48.54. BDH Industries' value of 26.43% is 45.6% below this benchmark. Historically, BDH Industries' own Gross Margin % has ranged from 25.82 to 40.03 over the past decade. While the company's 10-year median is 35.10 vs. the industry median of 48.54, BDH Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BDH Industries's current Gross Margin % of 26.43% is 45.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on BDH Industries and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BDH Industries's current Gross Margin % is 26.43%, which is 25% below median its own 10-year median of 35.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BDH Industries stock overvalued right now?
Based on GuruFocus' analysis, BDH Industries (BOM:524828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.10, compared to a current price of ₹581.35 — trading 48.6% above its estimated fair value. The current Gross Margin % is 26.43%, which is 25% below median its 10-year median of 35.10 and 45.6% below the Drug Manufacturers industry median of 48.54. BDH Industries' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For BDH Industries (BOM:524828), the current Gross Margin % is 26.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BDH Industries (BOM:524828) Overvalued in 2026?
Based on GuruFocus' analysis, BDH Industries stock appears to be overvalued.
The current stock price of ₹581.35 is trading 48.6% above its estimated GF Value™ of ₹391.10.
GuruFocus considers BDH Industries to be Significantly Overvalued.
Key valuation signals for BOM:524828:
Gross Margin %: 26.43% (25% below median its 10-year median of 35.10)
GF Value™: ₹391.10 vs. price of ₹581.35 (48.6% above fair value)
Industry Position: 45.6% below the Drug Manufacturers median (#790 of 942)
No single metric tells the full story. See the BOM:524828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The company has the following reportable segments; Pharmaceuticals and Renewable Energy. The majority of its revenue is generated from the Pharmaceuticals segment. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others.
78GF Score
Get the complete analysis for BOM:524828
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524828 has been successfully added to your 
